Does Pneumatosis Intestinalis after Etoposide Chemotherapy always have a Benign Course?

Yıl 2016, Cilt: 7 Sayı: 2, 24 - 26, 01.04.2016

Emre Salçın Serhad Ömercikoğlu Serkan Emre Eroğlu Haldun Akoğlu Özge Onur Arzu Denizbaşı

Öz

Introduction: Pneumatosis intestinalis (PI) was reported in hematological malignancies in immunosuppressive patients who were being administered chemotherapy and steroids. However, PI generally has a benign course and is usually conservatively treated in these patients. In this case, we presented a patient who underwent chemotherapy because of testis neoplasm and was admitted to the hospital with abdominal pain, vomiting, and high blood glucose levels, and the patient died because of PI and mesenteric ischemia.Case Report: A 38-year-old man who had type 1 diabetes mellitus and had undergone chemotherapy (bleomycin, etoposide, cisplatin, and corticosteroids) for testis neoplasm presented to the emergency room with abdominal pain. His blood glucose level was 547 mg/dL. In blood gases analyses, pH=7.30, cHCO3=15, and lactate=3.2 and ketone was positive in urine analyses. He had no specific finding on physical abdominal examination. He had undergone diabetic ketoacidosis treatment. Because his abdominal pain persisted, abdominal tomography was performed and diffuse intestinal wall necrosis and gas was observed in the portal system. He was operated and died in the intensive care unit after surgery.Conclusion: In the emergency department, it is important to be aware of mesenteric ischemia (MI), particularly in patients who undergone chemotherapy and who were admitted to the hospital with abdominal pain. Quick and further testing for MI is necessary

Anahtar Kelimeler

Pneumatosis intestinalis, mesenteric ischemia, abdominal pain, etoposide

Kaynakça

• Heng Y, Schuffler MD, Haggit RC, Rohrmann CA. Pneumatosis intetinalis: a review. Am J Gastroenterol 1995; 90: 1747-58
• Ernest D, Schneiderman D. Other diseases of the colon and rectum. In: Gastrointestinal Disease: Pathophysiology, Diagnosis, and Manage- ment. Sleisenger MH, Fodtran JS, Eds. Harcourt Brace Jonanovich, Phila- delphia: 1989. p. 1595.
• Kortmann B, Klar E. Recognizing acute mesenteric ischaemia too late: reasons and diagnostic approach from a surgical point of view. Zentral- bl Chir 2005; 130: 223-6. [CrossRef]
• Karabuga T, Yoldas O, Ozsan I, Yıldırım UM, Aydin U. Diagnostic laparos- copy for pneumatosis intestinalis: to do or not to do? Am J Emerg Med 2014; 32: 1555. [CrossRef]
• Lee HS, Cho YW, Kim KJ, Lee JS, Lee SS, Yang SK. A simple score for pre- dicting mortality in patients with pneumatosis intestinalis. Eur J Radiol. 2014; 83: 639-45. [CrossRef]
• Shih IL, Lu YS, Wang HP, Liu KL. Pneumatosis coli after etoposide chemo- theraphy for breast cancer. J Clin Oncol. 2007; 25: 1623-5. [CrossRef]
• Hashimoto S, Saitoh H, Wada K, Kobayashi T, Furushima H, Kawai H, et al. Pneumatosis cystoides intestinalis after chemotherapy for hematological malignancies: report of 4 cases. Intern Med. 1995; 34: 212-5. [CrossRef]
• Naranjo CA, Busto U, Sellers EM, Sandor P, Ruız I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981; 30: 239-45. [CrossRef]
• Priest E, Goldstein F. Pneumatosis cystoides intestinalis. In: Gastroenter- ology, Berk JE, Ed. WBSaunders, Philadelphia: 1985. p. 2474.
• Candelaria M, Bourlon-Cuellar R, Zubieta JL, Noel-Ettiene LM, Sanchez- Sanchez JM. Gastrointestinal pneumatosis after docetaxel chemothera- py. J Clin Gastroenterol. 2002; 34: 444-5. [CrossRef]